Tamsulosin Hydrochloride
Brand Names: Flomax
Methodology & AI Transparency ⓘ
Tamsulosin Hydrochloride Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) .
- 2 Real-world patient consensus: Real-world cohort score of 90% across 7 de-identified Tamsulosin Hydrochloride entries.
- 3 Typical cash cost range: Dispensing cost comparison spans $6.01 mail/discount cash up to $34.50 uninsured retail (federal NADAC $0.0515).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Tamsulosin Hydrochloride): nausea (12.1%), headache (10.7%), dizziness (6.4%).
Ask our AI Specialists anything about Tamsulosin Hydrochloride
Tamsulosin Hydrochloride Mechanism, CYP450 Pathways & DailyMed Monograph
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) . Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. Tamsulosin hydrochloride capsules are an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia (1) Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension (1)
12.1 Mechanism of Action The symptoms associated with benign prostatic hyperplasia (BPH) are related to bladder outlet obstruction, which is comprised of two underlying components: static and dynamic. The static component is related to an increase in prostate size caused, in part, by a proliferation of smooth muscle cells in the prostatic stroma. However, the severity of BPH symptoms and the degree of urethral obstruction do not correlate well with the size of the prostate. The dynamic component is a function of an increase in smooth muscle tone in the prostate and bladder neck leading to constriction of the bladder outlet.
Systemic exposure to Tamsulosin Hydrochloride reflects Oral fraction absorbed ranges from 47% to 59% (Tamsulosin Hydrochloride .4) absorption kinetics and biotransformed through cyp3a4, cyp2d6 pathways with mixed urinary/fecal clearance, sustaining receptor engagement across a Mean elimination half-life of 7 to 16 hours across adult Tamsulosin Hydrochloride dosing half-life window (oral tmax achieved within 2 to 4 hours following tamsulosin hydrochloride ingestion response profile).
Dosing protocols (.4 mg/1 Capsule or 0.4mg Capsule) balance efficacy (90.00% patient satisfaction across 7 logs) against nausea (12.1% of reports), headache (10.7% of reports), diarrhea (9.4% of reports), with strict avoidance in tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules.; reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms ..
Co-prescribing potent CYP3A4 inhibitors reduces metabolic elimination of Tamsulosin Hydrochloride and prolongs half-life.
Systemic bioavailability and half-life of Tamsulosin Hydrochloride respond to strong CYP3A4 enzymatic inhibition or induction.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules.
- Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms .
Logged Side-Effect Incidence (7 Reports)
Tamsulosin Hydrochloride Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tamsulosin Hydrochloride)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to: What a 1,144-Participant Study Found However, therapy discontinuation due to pain and AEs did not increase with increase in AEs. American journal of men's health • 2020-01-15 • Meta-Analysis | N = 1,144 | 94/100 | PMID 33342335 ↗ |
| New Insights on Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating: What a 1,531-Participant Study Found Tadalafil combined with tamsulosin was more effective in the treatment of male LUTS/BPH, with or without ED, on the improvement of total IPSS, QoL, and Qmax. Urologia internationalis • 2024-01-15 • Meta-Analysis | N = 1,531 | 94/100 | PMID 38081154 ↗ |
| New Insights on Benefits and safety of tadalafil 5 mg once-daily in Asian men with both lower: What a 361-Participant Study Found Tadalafil is efficacious and well tolerated in the treatment of Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction. International journal of urology : official journal of the Japanese Urological Association • 2019-02-15 • Phase III Randomized Trial | N = 361 | 93/100 | PMID 30362173 ↗ |
| New Insights on Tamsulosin plus Tadalafil compared with Tamsulosin alone for benign prostate: What a 940-Participant Study Found Combination therapy with tamsulosin and tadalafil demonstrated superior efficacy over tamsulosin single-drug treatment in reducing LUTS, improving quality of life, and enhancing erectile function. World journal of urology • 2025-05-11 • Meta-Analysis | N = 940 | 91/100 | PMID 40349279 ↗ |
| New Insights on Defining the real-world benefits and safety of Phosphodiesterase Type 5: What a 531-Participant Study Found This meta-analysis indicates that sildenafil combined with tamsulosin is the best effective and tolerated treatment option for BPH-LUTS with or without ED. BioMed research international • 2020-01-15 • Meta-Analysis | N = 531 | 91/100 | PMID 32309423 ↗ |
Tamsulosin Hydrochloride Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0515/unit (~$1.54/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $6.01 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 7 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Tamsulosin Hydrochloride Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Tamsulosin Hydrochloride RxNorm Concept ID | 863669 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0515 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $6.01 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 90.00% Worth It (7 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Tamsulosin Hydrochloride Patient Community, Cohort Filters & Dosage Logs
Deterministic Tamsulosin Hydrochloride reference combining NIH RxNorm (863669), Medicaid NADAC ($0.0515/unit), and anonymous cohort outcomes (90% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Tamsulosin Hydrochloride community threads and patient logs by age, biological sex, dosage, and treatment duration.